Skip to main content
Premium Trial:

Request an Annual Quote

QED Solutions New CSO Will Oversee Nascent Genomics Tech Division

NEW YORK, Dec. 10 — Genomics expert George F. Steinfels was named chief scientific officer of QED Solutions and general manager of the company's new genomics technology division, QNOME, the firm said on Monday.

 

With expertise in the application of genomic technologies to drug development, Steinfels will seek to improve and expand the company's Qscan dataset, which allows researchers to access drug profiles, monitor adverse drug events, analyze potential interactions, and correlate compounds with known drugs over the Internet. The new QNOME division, by comparison, is designed to use genome technology to help improve drug safety.

 

QED Solutions, of McLean, Va., was founded in 1998, and specializes in products that can be used to improve drug safety both for candidate drugs and approved pharmaceuticals.

 

Steinfels founded the consultant group Genomic Strategies and was previously chief operating officer of the pharmacogenomics business at Quintiles.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.